Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study

• Автори: Huiya Mei (Автор), Ruijin Xie (Автор), Tianxiao Li (Автор), Zongxin Chen (Автор), Yueying Liu (Автор), Chenyu Sun (Автор)
• Формат: Книга
• Опубліковано: MDPI AG, 2022-02-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

(1) Objective: Atomoxetine is a selective norepinephrine reuptake inhibitor used to treat attention-deficit/hyperactivity disorder (ADHD) in children over six years old. Although it is common knowledge that primary school children with ADHD often present with difficulties in the morning prior to sch...